Evidence map›Paper›PMID 24941225›Full record

ArticlePloS one2014

Genetic variations affecting serum carcinoembryonic antigen levels and status of regional lymph nodes in patients with sporadic colorectal cancer from Southern China.

Yu Liang, Weizhong Tang, Tiqiang Huang, Yong Gao, Aihua Tan, Xiaobo Yang, Haiying Zhang, Yanling Hu, Xue Qin, Shan Li and 12 more

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. International journal of medical sciences · 2017
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Yu LiangDepartment of Hepatobiliary Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
Weizhong TangDepartment of Anal and colorectal Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
Tiqiang HuangDepartment of Anal and colorectal Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
Yong GaoCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
Aihua TanCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
Xiaobo YangDepartment of Occupational Health and Environmental Health, School of Public Health, Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
Haiying ZhangDepartment of Occupational Health and Environmental Health, School of Public Health, Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
Yanling HuMedical Scientific Research Center, Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
Xue QinDepartment of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
Shan LiDepartment of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
Shijun ZhangCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
Linjian MoCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi, People's Republic of China; Institute of Urology and Nephrology, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
Zhenjia LiangMedical Examination Center, Fangchenggang First People's Hospital, Fangchenggang, Guangxi, People's Republic of China.
Deyi ShiMedical Examination Center, Fangchenggang First People's Hospital, Fangchenggang, Guangxi, People's Republic of China.
Zhang HuangMedical Examination Center, Guigang First People's Hospital, Guigang, Guangxi, People's Republic of China.
Yingyong GuanMedical Examination Center, Yulin First People's Hospital, Yulin, Guangxi, People's Republic of China.
Jicheng ZhouDepartment of Hematology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
Cheryl WinklerMolecular Genetics Epidemiology Sec., Frederick Nat. Lab for Cancer Research, National Cancer Institute, NIH, Frederick, Maryland, United States of America.
Stephen J O'BrienLaboratory of Genomic Diversity, National Cancer Institute, NIH, Frederick, Maryland, United States of America; Theodosius Dobzhansky Center for Genome Bioinformatics, St. Petersburg State University, St. Petersburg, Russia; Oceanographic Center, Nova Southeastern University, Ft. Lauderdale, Florida, United States of America.
Jianfeng XuCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi, People's Republic of China; Center for Cancer Genomics, Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States of America.
Zengnan MoCenter for Genomic and Personalized Medicine, Guangxi Medical University, Nanning, Guangxi, People's Republic of China; Institute of Urology and Nephrology, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
Tao PengDepartment of Hepatobiliary Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China; Laboratory of Genomic Diversity, National Cancer Institute, NIH, Frederick, Maryland, United States of America.

Funding

Identification of Genetic Factors Associated with Infectious DiseasesZIABC010297 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI WINKLER, CHERYL · 2009 to 2022
$6.3M
6 · The paper itself

Abstract

backgroundSerum carcinoembryonic antigen (sCEA) level might be an indicator of disease. Indeed, an elevated sCEA level is a prognostic factor in colorectal cancer (CRC) patients. However, the genetic determinants of sCEA level in healthy and CRC population remains unclear. Thus we investigated the genetic markers associated with elevated serum sCEA level in these two populations and its clinical implications. METHODS AND

findingsGenome-wide association study (GWAS) was conducted in a cohort study with 4,346 healthy male adults using the Illumina Omni 1 M chip. Candidate SNPs associated with elevated sCEA levels were validated in 194 CRC patients on ABI Taqman platform. Eight candidate SNPs were validated in CRC patients. The rs1047781 (chr19- FUT2) (A/T) was associated with elevated sCEA levels, and rs8176746 (chr9- ABO) was associated with the regional lymph metastasis in the CRC patients. The preoperative sCEA level was a risk factor for tumor recurrence in 5 years after operation (OR = 1.427, 95% CI: 1.005∼1.843, P = 0.006). It was also one of the risk factors for regional lymph node metastasis (OR = 2.266, 95% CI: 1.196∼4.293, P = 0.012). The sCEA level in rs1047781-T carriers was higher than that in the A carriers in CRC patients without lymph node metastasis (P = 0.006). The regional lymph node metastasis in patients with homozygote AA of rs8176746 was more common than that in the heterozygote AG carriers (P = 0.022). In addition, rs1047781-AT and TT CRC patients exhibited a worse disease-free survival than AA genotype carriers (P = 0.023).

conclusionsWe found candidate SNPs associated with elevated sCEA levels in both healthy males and CRC population. Rs1047781 (chr19- FUT2) may be the susceptible locus for recurrence of CRC in a population from Southern China.

Indexed as

Polymorphism, Single NucleotideAdenocarcinomaCarcinoembryonic AntigenChinaColorectal NeoplasmsDisease-Free SurvivalFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansKaplan-Meier EstimateLymphatic MetastasisMaleMiddle AgedRisk FactorsCarcinoembryonic Antigen

Identifiers

PMID24941225
PMCPMC4062418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.